Current Applications Differentiation into Insulin-Producing Cells Further applications for GLP1-RA, primarily Ex-4, on hMSC include the differentiation into insulin-producing cells (IPC), a process of significant interest for regenerative approaches in gastroenterology
Although traditionally considered to have limited efficacy in patients with diabetes, recent studies indicate that, when acting synergistically with GLP-1, GIP enhances insulinotropic effects and improves overall metabolic homeostasis (20, 21)
Additionally, general health and wellness resources can be included
The third is if you have one of the above two risk factors, and you also have a potential for heart disease
Diabetes Therapy, 15(2), 345357
GLP-1 analogues, like semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide, have garnered attention for their remarkable impact on weight management